These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6457419)

  • 21. Cancer immunology.
    Hersh EM
    Trans Stud Coll Physicians Phila; 1975 Jan; 42(3):234-6. PubMed ID: 1135940
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
    Ogura T
    Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
    [No Abstract]   [Full Text] [Related]  

  • 23. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
    Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
    Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer immunotherapy: immunologic bases, reality and hopes].
    Dietrich PY; Farace F; Caignard A; Escudier B; Triebel F
    Bull Cancer; 1993 Jul; 80(7):584-600. PubMed ID: 8204939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer vaccines: current status.
    Hwang LC; Fein S; Levitsky H; Nelson WG
    Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concepts in immunotherapy of cancer: introduction.
    Ioannides CG; Den Otter W
    In Vivo; 1991; 5(6):551-2. PubMed ID: 1810436
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metastasis. Natural history and therapeutic data].
    Scolozzi R; Boccafogli A; Furlani RF; Vicentini L
    Recenti Prog Med; 1982 Apr; 72(4):446-81. PubMed ID: 6216563
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outlook for the use of antitumor vaccines in the treatment and prevention of malignant neoplasms].
    Shuklinov VA; Shumilina VV
    Vopr Onkol; 1985; 31(8):3-10. PubMed ID: 3898578
    [No Abstract]   [Full Text] [Related]  

  • 32. [Paraspecific reactions of antigens: active immunotherapy of tumors. A review].
    Hochstein-Mintzel V
    Fortschr Med; 1976 Oct; 94(28):1565-70. PubMed ID: 61935
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology and cancer.
    McCulloch PB
    Can J Surg; 1976 Jan; 19(1):9-10. PubMed ID: 1245011
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunotherapy of cancer: evolution of concepts and clinical advances].
    Baldwin RW
    Rev Prat; 1980 Jan; 30(5):221-4, 227-8. PubMed ID: 6929557
    [No Abstract]   [Full Text] [Related]  

  • 36. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW; Moreno M; van der Vliet HJ; van den Eertwegh AJ; Scheper RJ; von Blomberg BM; Bontkes HJ
    Clin Immunol; 2008 Nov; 129(2):182-94. PubMed ID: 18783990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of cancer: a critical review.
    Lutz D
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):118-29. PubMed ID: 6343261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. beta-Glycosphingolipids as immune modulators.
    Adar T; Ilan Y
    J Immunotoxicol; 2008 Apr; 5(2):209-20. PubMed ID: 18569392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T regulatory cells, the evolution of targeted immunotherapy.
    Nizar S; Meyer B; Galustian C; Kumar D; Dalgleish A
    Biochim Biophys Acta; 2010 Aug; 1806(1):7-17. PubMed ID: 20188145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH; Hills D
    J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.